Literature DB >> 25972162

μ-Opioid Receptor-Mediated Inhibition of Intercalated Neurons and Effect on Synaptic Transmission to the Central Amygdala.

Peter Blaesse1, Lena Goedecke1, Michaël Bazelot2, Marco Capogna3, Hans-Christian Pape1, Kay Jüngling4.   

Abstract

The amygdala is a key region for the processing of information underlying fear, anxiety, and fear extinction. Within the local neuronal networks of the amygdala, a population of inhibitory, intercalated neurons (ITCs) modulates the flow of information among various nuclei of amygdala, including the basal nucleus (BA) and the centromedial nucleus (CeM) of the amygdala. These ITCs have been shown to be important during fear extinction and are target of a variety of neurotransmitters and neuropeptides. Here we provide evidence that the activation of μ-opioid receptors (MORs) by the specific agonist DAMGO ([D-Ala2,N-Me-Phe4,Gly5-ol]-Enkephalin) hyperpolarizes medially located ITCs (mITCs) in acute brain slices of mice. Moreover, we use whole-cell patch-clamp recordings in combination with local electrical stimulation or glutamate uncaging to analyze the effect of MOR activation on local microcircuits. We show that the GABAergic transmission between mITCs and CeM neurons is attenuated by DAMGO, whereas the glutamatergic transmission on CeM neurons and mITCs is unaffected. Furthermore, MOR activation induced by theta burst stimulation in BA suppresses plastic changes of feedforward inhibitory transmission onto CeM neurons as revealed by the MOR antagonist CTAP d-Phe-Cys-Tyr-d-Trp-Arg-Thr-Pen-Thr-NH2. In summary, the mITCs constitute a target for the opioid system, and therefore, the activation of MOR in ITCs might play a central role in the modulation of the information processing between the basolateral complex of the amygdala and central nuclei of the amygdala.
Copyright © 2015 Blaesse, Goedecke et al.

Entities:  

Keywords:  MOR; central amygdala; opioids; plasticity

Mesh:

Substances:

Year:  2015        PMID: 25972162      PMCID: PMC4429148          DOI: 10.1523/JNEUROSCI.0204-15.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  35 in total

Review 1.  Molecular mechanisms and regulation of opioid receptor signaling.

Authors:  P Y Law; Y H Wong; H H Loh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

2.  Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray.

Authors:  S A Tershner; F J Helmstetter
Journal:  Brain Res       Date:  2000-05-19       Impact factor: 3.252

Review 3.  Endomorphins: novel endogenous mu-opiate receptor agonists in regions of high mu-opiate receptor density.

Authors:  J E Zadina; S Martin-Schild; A A Gerall; A J Kastin; L Hackler; L J Ge; X Zhang
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

4.  Bidirectional synaptic plasticity in intercalated amygdala neurons and the extinction of conditioned fear responses.

Authors:  S Royer; D Paré
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 5.  Contextual inhibitory gating of impulse traffic in the intra-amygdaloid network.

Authors:  Denis Paré; Sébastien Royer; Yoland Smith; Eric J Lang
Journal:  Ann N Y Acad Sci       Date:  2003-04       Impact factor: 5.691

6.  Synaptic properties and postsynaptic opioid effects in rat central amygdala neurons.

Authors:  W Zhu; Z Z Pan
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

7.  Mu and delta receptors belong to a family of receptors that are coupled to potassium channels.

Authors:  R A North; J T Williams; A Surprenant; M J Christie
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  Regional mu opioid receptor regulation of sensory and affective dimensions of pain.

Authors:  J K Zubieta; Y R Smith; J A Bueller; Y Xu; M R Kilbourn; D M Jewett; C R Meyer; R A Koeppe; C S Stohler
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

9.  Endogenous opioids regulate long-term potentiation of synaptic inhibition in the dentate gyrus of rat hippocampus.

Authors:  C W Xie; D V Lewis
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

10.  Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse.

Authors:  Nobuaki Tamamaki; Yuchio Yanagawa; Ryohei Tomioka; Jun-Ichi Miyazaki; Kunihiko Obata; Takeshi Kaneko
Journal:  J Comp Neurol       Date:  2003-12-01       Impact factor: 3.215

View more
  22 in total

Review 1.  Endogenous opioid peptides in the descending pain modulatory circuit.

Authors:  Elena E Bagley; Susan L Ingram
Journal:  Neuropharmacology       Date:  2020-05-15       Impact factor: 5.250

Review 2.  Bridging the Gap: Towards a cell-type specific understanding of neural circuits underlying fear behaviors.

Authors:  K M McCullough; F G Morrison; K J Ressler
Journal:  Neurobiol Learn Mem       Date:  2016-07-26       Impact factor: 2.877

3.  Loss of Intercalated Cells (ITCs) in the Mouse Amygdala of Tshz1 Mutants Correlates with Fear, Depression, and Social Interaction Phenotypes.

Authors:  Jeffrey Kuerbitz; Melinda Arnett; Sarah Ehrman; Michael T Williams; Charles V Vorhees; Simon E Fisher; Alistair N Garratt; Louis J Muglia; Ronald R Waclaw; Kenneth Campbell
Journal:  J Neurosci       Date:  2017-12-18       Impact factor: 6.167

4.  Calcium signalling in medial intercalated cell dendrites and spines.

Authors:  Cornelia Strobel; Robert K P Sullivan; Peter Stratton; Pankaj Sah
Journal:  J Physiol       Date:  2017-07-16       Impact factor: 5.182

Review 5.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

6.  Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABAA receptor encephalitis.

Authors:  Simone M Brändle; Manuela Cerina; Susanne Weber; Kathrin Held; Amélie F Menke; Carmen Alcalá; David Gebert; Alexander M Herrmann; Hannah Pellkofer; Lisa Ann Gerdes; Stefan Bittner; Frank Leypoldt; Bianca Teegen; Lars Komorowski; Tania Kümpfel; Reinhard Hohlfeld; Sven G Meuth; Bonaventura Casanova; Nico Melzer; Eduardo Beltrán; Klaus Dornmair
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

Review 7.  Amygdala, neuropeptides, and chronic pain-related affective behaviors.

Authors:  Volker Neugebauer; Mariacristina Mazzitelli; Bryce Cragg; Guangchen Ji; Edita Navratilova; Frank Porreca
Journal:  Neuropharmacology       Date:  2020-03-15       Impact factor: 5.250

8.  Biased signaling by endogenous opioid peptides.

Authors:  Ivone Gomes; Salvador Sierra; Lindsay Lueptow; Achla Gupta; Shawn Gouty; Elyssa B Margolis; Brian M Cox; Lakshmi A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-11       Impact factor: 11.205

9.  Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.

Authors:  Yun K Hahn; Jason J Paris; Aron H Lichtman; Kurt F Hauser; Laura J Sim-Selley; Dana E Selley; Pamela E Knapp
Journal:  Neurobiol Dis       Date:  2016-02-01       Impact factor: 5.996

Review 10.  Incentive motivation: 'wanting' roles of central amygdala circuitry.

Authors:  Shelley M Warlow; Kent C Berridge
Journal:  Behav Brain Res       Date:  2021-05-20       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.